XML 52 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table summarizes the stock option activity during the year ended December 31, 2023:
Shares Weighted Average
Exercise Price
Weighted Average
Remaining Contractual Term
(in Years)
Aggregate
Intrinsic Value
(in thousands)
Outstanding, January 1, 20232,990,423 $19.28 8.59$2,849 
Granted2,282,409 8.78 
Exercised(41,633)1.88 
Expired/cancelled(651,540)19.98 
Outstanding as of December 31, 20234,579,659 $14.11 8.37$25 
Options exercisable as of December 31, 20231,494,789 $17.84 7.22$25 
Vested and expected to vest as of December 31, 20234,579,659 $14.11 8.37$25 
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity
Activity with respect to the Company’s restricted stock units during the year ended December 31, 2023 is as follows:
SharesWeighted Average
Grant Date Fair Value
Nonvested shares at January 1, 2023— $ 
Granted32,558 4.30 
Vested/Issued— — 
Forfeited— — 
Nonvested shares at December 31, 202332,558 $4.30 
Schedule of Recognized Compensation Cost Restricted Stock Units
The Company recognized the following compensation cost related to employee and non-employee share-based compensation activity for the periods presented (in thousands):
Year Ended December 31,
20232022
Selling, general and administrative$7,450 $6,333 
Research and development4,504 3,310 
Total$11,954 $9,643 
Schedule of Stock Options Valuation Assumptions
The calculation was based on the following assumptions:
Year Ended December 31,
20232022
Weighted average grant date fair value (per share)$6.83$12.20
Risk-free interest rate
3.42% - 4.67%
1.46% - 4.23%
Expected volatility
89.94% - 101.49%
85.91% - 89.35%
Expected term (in years)
5.2 - 6.1
5.5 - 6.1
Expected dividend yield